April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
A new Tool for Transfection of Corneal Endothelial Cells using Calcium Phosphate Nanoparticles
Author Affiliations & Notes
  • Jun Hu
    Ophthalmology Department, Tongji Hospital,Tongji Medical College,HUST, Wuhan, China
    Institute of Anatomy, Essen University Hospital, Essen, Germany
  • Anna kovtun
    Inorganic Chemistry, University Duisburg-Essen, Essen, Germany
  • Bernhard B Singer
    Institute of Anatomy, Essen University Hospital, Essen, Germany
  • Anke Tomaszewski
    Institute of Anatomy, Essen University Hospital, Essen, Germany
    Center of Ophthalmology, Essen University Hospital, Essen, Germany
  • Berthold Seitz
    University Eye Hospital, Homburg/Saar, Homburg, Germany
  • Matthias Epple
    Inorganic Chemistry, University Duisburg-Essen, Essen, Germany
  • Klaus-Peter Steuhl
    Center of Ophthalmology, Essen University Hospital, Essen, Germany
  • Süleyman Ergün
    Institute of Anatomy, Essen University Hospital, Essen, Germany
  • Thomas Armin Fuchsluger
    Institute of Anatomy, Essen University Hospital, Essen, Germany
    Center of Ophthalmology, Essen University Hospital, Essen, Germany
  • Footnotes
    Commercial Relationships  Jun Hu, None; Anna kovtun, None; Bernhard B Singer, None; Anke Tomaszewski, None; Berthold Seitz, None; Matthias Epple, None; Klaus-Peter Steuhl, None; Süleyman Ergün, None; Thomas Armin Fuchsluger, None
  • Footnotes
    Support  the KC Wong Foundation / DAAD grant
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6462. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jun Hu, Anna kovtun, Bernhard B Singer, Anke Tomaszewski, Berthold Seitz, Matthias Epple, Klaus-Peter Steuhl, Süleyman Ergün, Thomas Armin Fuchsluger; A new Tool for Transfection of Corneal Endothelial Cells using Calcium Phosphate Nanoparticles. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6462.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Calcium phosphate nanoparticles (CaP-NPs) are an ideal tool for transfection thanks to their distinct biocompatibility. After transfection, the particles dissolve in calcium and phosphate, and it has been shown that intracellular Ca2+ - levels do not affect cell viability. The aim of this study was to compare the transfection efficiencies of different CaP-NPs in corneal endothelial cells.

Methods: : Different CaP-NPs with pcDNA3-EGFP (triple-shell CaP/DNA/CaP/DNA in different preparations and those coated by various dispersions of polyethylenimine (PEI) were prepared. Polyfect-pcDNA3-EGFP served as positive control. Human and murine corneal endothelial cells (suspensions and donor tissue) were transfected with varying concentrations of CaP-NPs, for different transfection periods. The transfection efficiency was measured by EGFP-expression measured by quantitative flow cytometry and fluorescence microscopy. To evaluate a possible cell toxicity, apoptosis was studied by propidium iodide or TUNEL staining.

Results: : Coating with PEI significantly increased the transfection efficiency of triple shell CaP-NPs. Thus, after transfection with triple shell CaP-NPs/PEI(0.5), up to 50% of corneal endothelial cells showed EGFP expression. However, the cell viability in cell suspensions decreased with increasing dispersion of PEI. As corneal endothelial cells are a cell type with minimal proliferative capacity, the EGFP expression in tissues remained considerably stable.

Conclusions: : CaP-NPs are suitable tools for the transfection of corneal endothelial cells and may offer an alternative to viral transfection which is safe for patient use. Further studies are necessary to carefully evaluate the aspects of functional application and of biosafety.

Keywords: cornea: endothelium • calcium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×